Welcome to our dedicated page for Healthlynked SEC filings (Ticker: HLYK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to gauge HealthLynked’s telehealth momentum or see when executives buy shares? Investors often start with a single question—then meet hundreds of pages of technical language. This page brings every HealthLynked SEC filing into one clear workflow.
Begin with the documents people search for most: the HealthLynked quarterly earnings report 10-Q filing reveals subscription growth and patient engagement trends, while the HealthLynked annual report 10-K simplified outlines long-term strategy, HIPAA compliance costs, and platform expansion risks. Need breaking news? The HealthLynked 8-K material events explained section flags partnership announcements and technology updates minutes after they hit EDGAR.
Our AI-powered summaries translate dense accounting notes into plain English. Use them to answer real questions fast, such as “What are HealthLynked insider trading Form 4 transactions telling me?” or “How is executive compensation detailed in the HealthLynked proxy statement executive compensation filing?” Real-time alerts for HealthLynked Form 4 insider transactions real-time help you monitor executive stock transactions Form 4 before the market reacts.
- Track telemedicine revenue shifts without sifting through footnotes
- Compare quarter-over-quarter user adoption in seconds
- Spot potential catalysts inside HealthLynked earnings report filing analysis
Whether you’re understanding HealthLynked SEC documents with AI for the first time or drilling into historical data, every 10-K, 10-Q, 8-K, S-1, and Form 4 is indexed, searchable, and cross-linked. Complex disclosures become actionable insights—no legalese required. That’s HealthLynked SEC filings explained simply.
HealthLynked Corp. (HLYKD) reported lower sales and continued losses for the quarter ended September 30, 2025. Total revenue was $388,545 versus $590,124 a year earlier, as patient service, subscription, and product revenue all declined. For the first nine months of 2025, revenue was $1,755,113 compared with $2,389,434 in the prior-year period.
The company posted a quarterly net loss of $851,800 and a nine‑month net loss of $2,603,777, though both were smaller than the prior year. Operating expenses fell year over year, helped by the absence of a $716,000 impairment charge recorded in 2024 and lower practice and overhead costs.
HealthLynked’s balance sheet remains strained. As of September 30, 2025, cash was $10,911, total assets were $1,764,557, and shareholders’ deficit widened to $5,433,415. Current liabilities of $6,744,301 included significant related‑party convertible debt, third‑party notes, and lease obligations. Management disclosed a substantial doubt about the company’s ability to continue as a going concern through November 19, 2026 without additional capital.
During the period, HealthLynked executed a 1‑for‑100 reverse stock split, reducing outstanding common shares from 284,750,832 to 2,847,873, and later agreed to sell its BTG physical therapy practice assets for $125,000 in cash.
FAQ
What is the current stock price of Healthlynked (HLYK)?
What is the market cap of Healthlynked (HLYK)?
